Security Snapshot

Teva Pharmaceutical Industries Ltd - Ordinary Shares, par value NIS 0.10 per share Institutional Ownership

CUSIP: M8769Q102

13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Shares outstanding
1,148,024,683
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • M8769Q102 - Teva Pharmaceutical Industries Ltd - Ordinary Shares, par value NIS 0.10 per share is tracked under CUSIP M8769Q102.
  • Latest finished 13F holder period is not available.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 1 to 0 between Q3 2025 and Q4 2025.
  • SEC-reported value moved from $637,613 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

M8769Q102

Latest holder period

n/a

13F holders

13D/G owners

2

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
M8769Q102
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Harel Insurance Investments & Financial Services Ltd. 6.3% +24% +$286,988,127 72,325,555 +24% Harel Insurance Investments & Financial Services Ltd 31 Dec 2025
FMR LLC 2.1% -60% -$561,363,714 24,641,361 -58% FMR LLC 30 Sep 2025

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
3
Latest
n/a
Rows shown
1-3 of 3
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$637,613 0
2025 Q3 31,565 $637,613 -$257,126 $20.20 1
2025 Q2 44,294 $742,367 +$742,367 $16.76 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .